Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2551
CALL
Invesco
IVZ
$13.9B
| $1.14M | ﹤0.01% |
42,700
| – | – |
|
2552
El Pollo Loco
LOCO
$462M
| $1.14M | ﹤0.01% |
62,425
+25,368
| +68% | +$434K |
|
2553
Fulgent Genetics
FLGT
$527M
| $1.14M | ﹤0.01% |
12,363
-6,216
| -33% | -$496K |
|
|
COWN
2554
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.14M | ﹤0.01% |
27,789
-45,655
| -62% | -$1.79M |
|
2555
CALL
Avis
CAR
$5.02B
| $1.14M | ﹤0.01% |
14,600
-27,000
| -65% | -$2.24M |
|
2556
PUT
Celanese
CE
$4.82B
| $1.14M | ﹤0.01% |
7,500
| – | – |
|
2557
AtriCure
ATRC
$2.11B
| $1.13M | ﹤0.01% |
14,285
-68,293
| -83% | -$4.96M |
|
2558
Northrim BanCorp
NRIM
$587M
| $1.13M | ﹤0.01% |
105,724
-17,316
| -14% | -$188K |
|
2559
Advanced Drainage Systems
WMS
$11B
| $1.13M | ﹤0.01% |
9,687
-38,192
| -80% | -$4.24M |
|
|
BERY
2560
DELISTED
Berry Global Group, Inc.
BERY
| $1.13M | ﹤0.01% |
18,807
-26,418
| -58% | -$1.59M |
|
2561
Provident Financial Services
PFS
$3.19B
| $1.13M | ﹤0.01% |
49,174
-40,241
| -45% | -$971K |
|
2562
1st Source
SRCE
$2.12B
| $1.12M | ﹤0.01% |
24,189
-2,583
| -10% | -$124K |
|
2563
Ternium
TX
$10.6B
| $1.12M | ﹤0.01% |
29,189
+4,004
| +16% | +$153K |
|
2564
iShares Fallen Angels USD Bond ETF
FALN
$1.62B
| $1.12M | ﹤0.01% |
+37,411
| New | +$1.1M |
|
2565
Milestone Pharmaceuticals
MIST
$152M
| $1.12M | ﹤0.01% |
203,901
+47,025
| +30% | +$267K |
|
2566
Griffon
GFF
$4.86B
| $1.12M | ﹤0.01% |
43,697
-19,760
| -31% | -$527K |
|
2567
Community Trust Bancorp
CTBI
$1.41B
| $1.11M | ﹤0.01% |
27,618
-10,827
| -28% | -$475K |
|
2568
Genesco
GCO
$422M
| $1.11M | ﹤0.01% |
17,504
-1,077
| -6% | -$58.4K |
|
2569
CALL
AES
AES
$10.5B
| $1.11M | ﹤0.01% |
+42,700
| New | +$1.13M |
|
|
DCPH
2570
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.11M | ﹤0.01% |
30,393
-59,974
| -66% | -$2.32M |
|
2571
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
| $1.11M | ﹤0.01% |
23,127
+16,931
| +273% | +$811K |
|
2572
PetMed Express
PETS
$42.3M
| $1.11M | ﹤0.01% |
34,813
+8,345
| +32% | +$265K |
|
2573
RBC Bearings
RBC
$18B
| $1.11M | ﹤0.01% |
5,548
-15,677
| -74% | -$3.1M |
|
2574
PUT
C.H. Robinson
CHRW
$17.5B
| $1.1M | ﹤0.01% |
11,800
| – | – |
|
|
SHOE
2575
Shoe Station Group
SHOE
$428M
| $1.1M | ﹤0.01% |
30,812
-890
| -3% | -$28.8K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.